☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Clinic
PharmaShots Interview: Entrada's Dipal Doshi Shares Insights on the Series B Funding Utilize to Advance DMD Program into the Clini...
May 19, 2021
Hanx Biopharmaceuticals Reports the First Patient Dosing with HX044 in P-I Clinical Evaluation
January 3, 2025
Xgene Pharmaceutical Reports Results from P-IIb Trial of XG005 for Post-Surgical Pain
January 2, 2025
ADC Therapeutics Reports Enrollment Completion in P-III (LOTIS-5) Study of Zynlonta Plus Rituximab for 2L+ Diffuse Large B-Cell Ly...
January 1, 2025
Axsome Therapeutics Reports Data from P-III (ACCORD-2 & ADVANCE-2) Trials of AXS-05 in Alzheimer’s Disease Agitation
December 31, 2024
CARsgen Therapeutics Reports Topline Results from P-II Study of Satricabtagene Autoleucel (Satri-cel) to Treat G/GEJ Cancer in Chi...
December 31, 2024
Novartis Reports Data from P-III (STEER) Study of Onasemnogene Abeparvovec to Treat Children and Young Adults with Spinal Muscular...
December 30, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.